Mechanistic analysis of ATR signaling
ATR信号传导机制分析
基本信息
- 批准号:9448654
- 负责人:
- 金额:$ 33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-08 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:ATR geneAddressBindingBiochemicalBiochemistryBioinformaticsBiological AssayBooksCancer BiologyCell CycleCell Cycle ProgressionCellsClinical TrialsClosure by clampComplexCrowdingCultured CellsDNADNA BindingDNA DamageDNA Double Strand BreakDNA RepairDNA biosynthesisDataDevelopmentEventFeedbackGenotoxic StressGoalsHumanIn VitroLearningLesionLinkMapsModelingMolecular ConformationNormal CellNuclear ProteinsPathologicPathway interactionsPatientsPharmaceutical PreparationsPhosphorylationPhosphotransferasesProtein KinaseProteinsRecruitment ActivityReportingResearchSignal TransductionSiteSlideStressSystemTOPBP1 GeneTREX1 geneTestingThinkingTimeTravelWorkXenopusanti-cancer therapeuticbasecancer cellcell transformationdesigneggexhaustionexperimental studyin vivoinhibitor/antagonistphysical propertypre-clinicalpreclinical studypreventprogramsprotein complexprotein protein interactionresearch clinical testingresponsescaffoldtumorigenesis
项目摘要
Project Summary/Abstract
The ATR protein kinase sits atop a complex signaling cascade that is activated by DNA replication and hyper-
activated by replication stress or DNA double-strand breaks. Activation of ATR by genotoxic stress is essential
for the ability of cells to survive stress and represents a barrier to transformation of normal cells to a
pathological condition that promotes tumorigenesis. The downstream effectors and consequences of ATR
signaling are now being understood, however early events in signaling, such as the initial activation of ATR
kinase at sites of gentoxic stress, are still poorly understood. This proposal focuses on the biochemical
mechanism for ATR activation at sites of DNA damage. This proposal features the TOPBP1 protein, which
physically interacts with ATR at sites of DNA damage and is required for ATR activation during the replication
stress and DNA damage responses. TOPBP1 is a BRCT repeat containing protein that likely acts as a scaffold to
link checkpoint proteins together into active signaling centers. In this proposal we combine biochemical
studies using purified factors, functional studies in Xenopus egg extracts, and in vivo studies in cultured cells
to mount an in-depth exploration of how TOPBP1 activates ATR at sites of DNA damage. Recent studies on the
ETAA1 protein have shown that TOPBP1 is not alone in its ability to activate ATR, and our preliminary studies
suggest that a third and possibly more ATR activators are present in human cells. In this proposal we will also
study these new activators, with the long-term goal of building a comprehensive, systems-level view of how
ATR signaling is initiated.
The work is divided into three Aims. In Aim 1, we examine how active ATR signaling centers form at sites of
damage. The recruitment mechanism is complex, and likely involves multiple protein-protein interactions
between TOPBP1 and its binding partners. Recent work from our group has shown that soluble TOPBP1 is held
in an auto-inhibitory conformation and thus an additional goal of Aim 1 is to determine how this auto-
inhibition is resolved at sites of damage. In Aim 2 we examine how ATR may use a negative feedback loop to
regulate assembly of additional signaling centers at sites of damage. We will also explore the possibility that an
ATR signaling center is mobile on DNA. In the final Aim we will define a rule-book for how different ATR
activators are utilized, how their functions are related (or not), and how their activities are integrated during an
ATR response.
项目总结/摘要
ATR蛋白激酶位于一个复杂的信号级联反应的顶部,该信号级联反应由DNA复制和超增殖激活。
由复制应激或DNA双链断裂激活。遗传毒性应激激活ATR是必不可少的
是细胞在压力下生存的能力,是正常细胞转化为
促进肿瘤发生的病理状态。ATR的下游效应和后果
信号传导现在被理解,然而信号传导中的早期事件,例如ATR的初始激活,
激酶在基因毒性应激位点的作用仍然知之甚少。该提案侧重于生物化学
在DNA损伤位点的ATR激活机制。该提案以TOPBP 1蛋白为特征,
在DNA损伤位点与ATR发生物理相互作用,并在复制过程中为ATR激活所需
应激和DNA损伤反应。TOPBP 1是一种含有BRCT重复序列的蛋白质,可能充当支架,
将检查点蛋白连接到活性信号中心。在这个提议中,我们将联合收割机
使用纯化因子的研究、爪蟾卵提取物的功能研究和培养细胞的体内研究
深入探索TOPBP 1如何在DNA损伤位点激活ATR。最近关于
ETAA 1蛋白已经表明TOPBP 1不是唯一具有激活ATR的能力,我们的初步研究表明,
这表明第三种和可能更多的ATR激活剂存在于人类细胞中。在这份提案中,我们还将
研究这些新的激活剂,长期目标是建立一个全面的、系统级的视图,了解如何
ATR信令被启动。
这项工作分为三个目标。在目标1中,我们研究了如何在活动的ATR信号中心形成的网站,
损害募集机制是复杂的,可能涉及多种蛋白质-蛋白质相互作用
TOPBP 1和它的结合伙伴之间的关系。我们小组最近的工作表明,可溶性TOPBP 1
因此,目标1的另一个目标是确定这种自动抑制构象是如何发生的。
抑制作用在损伤部位被消除。在目标2中,我们研究了ATR如何使用负反馈回路,
调节损伤部位额外信号中心的组装。我们还将探讨一种可能性,
ATR信号中心在DNA上是移动的。在最后的目标,我们将定义一个规则书,如何不同的ATR
如何使用激活器,它们的功能如何相关(或不相关),以及它们的活动在
ATR反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MATTHEW MICHAEL其他文献
MATTHEW MICHAEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MATTHEW MICHAEL', 18)}}的其他基金
Molecular mechanisms for germline genome activation in C. elegans
线虫种系基因组激活的分子机制
- 批准号:
10092192 - 财政年份:2019
- 资助金额:
$ 33万 - 项目类别:
Molecular mechanisms for germline genome activation in C. elegans
线虫种系基因组激活的分子机制
- 批准号:
10081929 - 财政年份:2019
- 资助金额:
$ 33万 - 项目类别:
Molecular mechanisms for germline genome activation in C. elegans
线虫种系基因组激活的分子机制
- 批准号:
10337245 - 财政年份:2019
- 资助金额:
$ 33万 - 项目类别:
ATR-Chk1 signaling during embryonic and germ line development in C. elegans
秀丽隐杆线虫胚胎和种系发育过程中的 ATR-Chk1 信号传导
- 批准号:
8218081 - 财政年份:2012
- 资助金额:
$ 33万 - 项目类别:
ATR-Chk1 signaling during embryonic and germ line development in C. elegans
秀丽隐杆线虫胚胎和种系发育过程中的 ATR-Chk1 信号传导
- 批准号:
8415514 - 财政年份:2012
- 资助金额:
$ 33万 - 项目类别:
ATR-Chk1 signaling during embryonic and germ line development in C. elegans
秀丽隐杆线虫胚胎和种系发育过程中的 ATR-Chk1 信号传导
- 批准号:
8610930 - 财政年份:2012
- 资助金额:
$ 33万 - 项目类别:
ATR-Chk1 signaling during embryonic and germ line development in C. elegans
秀丽隐杆线虫胚胎和种系发育过程中的 ATR-Chk1 信号传导
- 批准号:
8798672 - 财政年份:2012
- 资助金额:
$ 33万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 33万 - 项目类别:
Research Grant